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doi:10.1016/j.pedneo.2010.12.003Background: Pharmaceuticals involved in childhood poisoning vary, and treatment of poison
exposure can be a challenge for primary physicians when children are unconscious or histories
are lacking. Knowledge of the clinical manifestations and prognosis of poisoning will help
primary physicians perform appropriate clinical assessments. In this study, we aim to report
on patient characteristics, outcomes, and clinical features of pediatric poisoning in the emer-
gency department.
Methods: We retrospectively evaluated the medical records of 87 children younger than 18
years of age and presented to the emergency department with pharmaceutical poisoning
(2001e2008). The detailed categories of pharmaceutical were reported, and their associations
with patient outcomes were analyzed. Furthermore, children were divided into two groups,
based on the reasons for poison exposure (accidental or intentional poisoning). Clinical
features and outcomes between accidental or intentional poisoning were analyzed, and the
cut-off age for high risk of intentional poisoning was also calculated.of Pediatrics, Buddhist Tzu Chi General Hospital, Taichung Branch, No. 66, Sec. 1, Fongsing Road,
743, Taiwan.
.com (H.-P. Wu).
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12 Y.-R. Lin et alResults: Age groups of adolescents (48.3%) and preschool age (32.2%) children were the major
representation. Neurologic system agents (48.3%) and analgesics (18.4%) were the most
common causes of poisoning. Among the two major agents above, anxiolytic/hypnotic drugs
(lorazepam) and acetaminophen were the most frequent causes. Of all children, 70.1% had
duration of major symptoms for 1 day, and intentional poisoning caused significantly longer
duration of hospital stay than accidental poisoning did (pZ 0.008). Moreover, female gender
(p< 0.001), older age (p< 0.001), and analgesics (pZ 0.008) were more predominantly asso-
ciated with intentional poisoning in children, and the cut-off age for high risk of intentional
poisoning was over 10.5 years.
Conclusion: Neurologic system agents and analgesics were responsible for the majority of
cases. Intentional poisoning caused longer hospital length of stay than accidental poisoning,
and the factors associated with intentional poisoning were older age, female, and neurologic
system agents.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Pharmaceuticals involved in childhood poisoning vary, and
treatment of poison exposure can be a challenge for the
emergency department (ED) physicians when children are
unconscious or past histories are lacking. Epidemiological
studies on pediatric poisoning have demonstrated that the
most common risk factors for poison exposure are young
age, female gender, low education level of patients and
family members, and low socioeconomic status.1e9 More-
over, the outcome of poison exposure in children is depen-
dent on the category and the dosage of pharmaceutical.10,11
Previous studies reported that the most common categories
of poison in children were different in various global loca-
tions. For example, neurologic drugs were the most common
in France and analgesics were the most common in
Turkey.1,2 Previous study in Taiwan also reported that male
exposures were more prevalent than females, and acci-
dental exposures accounted for 77.7% of the cases, andmost
were exposed by the oral route.12 However, the clinical
features and prognosis, including the duration of major
symptoms and the hospital length of stay between the
different categories of pharmaceutical in children, have not
been well addressed. In this study, we have analyzed the
patient characteristics, outcomes, and clinical features of
pediatric pharmaceutical poisoning in central Taiwan.
2. Materials and Methods
2.1. Study design
Children aged <18 years, who presented to the ED of
Changhua Christian Hospital with pharmaceutical poison
exposure during the period January 2001 to January 2008,
were included in this study. Patient characteristics and
categories of pharmaceutical that might be associated with
the outcomes of children were analyzed.
2.2. Study setting and population
We retrospectively reviewed the medical records of 87
children aged 18 years with pharmaceutical poisonexposure, who presented to the ED at Changhua Christian
Hospital in central Taiwan (2000-bed medical center). ICD-
9 codes 960.0e979.9 were used for data search. Pharma-
ceutical poison exposure was defined as the ingestion,
either accidentally or intentionally, of pharmaceutical
substances at doses that elicited a toxic response. Children
in whom poisoning was because of nonpharmaceutical
substances (foods or envenomations) and pharmaceuticals
which could not be identified were not included in this
study. Children treated for pharmaceutical poison exposure
were required to remain in the pediatric ED for observation
or were hospitalized until vital signs stabilized and major
symptoms subsided. Patients in this study were divided into
six major groups based on the categories of pharmaceu-
tical: (1) neurologic system agents (anxiolytic/hypnotic
agents, antidepressant agents, antiepileptic drugs, and
narcotics); (2) analgesics (acetaminophen and nonsteroid
anti-inflammatory drugs); (3) respiratory system agents
(bronchodilators and dextromethorphan); (4) cardiovas-
cular system agents (antihypertensive drugs and anticoag-
ulants); (5) metabolic and nutrient agents (vitamins and
iron); and (6) others.
2.3. Study protocol
Information relating to the poison exposure was obtained
from medical records and witness statements. All data
were identified and abstracted by ED physicians. Demo-
graphic data gathered from ED patient charts included
gender, age at onset, category of pharmaceutical, clinical
presentations, the duration of major symptoms, place of
poison exposure, route of exposure, past history of phar-
maceutical poison, reason for poison exposure (accidental
or intentional), treatments, outcomes, period from poison
exposure to arrival at hospital, duration of observation at
the ED, and duration of hospitalization. The reason for and
the place of poison exposure were selfreported by family
members, patients, or witnesses. The duration of major
symptoms, as evaluated by physicians, comprised the
period from the onset of symptoms to subsidence of
symptoms.
The clinical presentations were categorized into seven
major groups of constitutional symptoms: (1) asymptomatic
Pharmaceutical poisoning exposure in children 13(without any uncomfortable symptoms or chief complaints,
and there was no specific finding after physical examina-
tions in the ED); (2) gastrointestinal symptoms (nausea,
vomiting, diarrhea, constipation, abdominal pain); (3)
neurological symptoms (dizziness, vertigo, convulsion,
headache, consciousness change); (4) respiratory tract
symptoms (cough, dyspnea); (5) cardiovascular symptoms
(brady/tachycardia, cardiac dysrhythmia, hypo/hyperten-
sion); (6) multiple symptoms (two or more symptoms); and
(7) others.
Among these six major categories of substances, patient
characteristics, clinical managements, and the total
hospital length of stay were analyzed for individual differ-
ences. The clinical managements associated with the
severity of symptoms were divided into two major groups:
(1) only ED course [discharge from hospital directly and
pediatric observation unit (POU) observation]; and (2)
hospital admission [ward admission and pediatric intensive
care unit (PICU) admission]. Patients who were asymp-
tomatic or suffering from mild clinical presentation could
be discharged from hospital directly or observed in the
POU. The POU was designed for children who do not require
an inpatient admission, but need to stay in the hospital for
further observation and short-term treatment. Once in the
POU, these patients were evaluated, orders were reviewed
by physicians, and they could be discharged home from POU
if they were clinically stable. Sometimes, the patients
required inpatient admission if they were not clinically
stable during observation. Otherwise, patients with severe
clinical presentation required hospital admission, and those
with unstable vital signs (i.e., respiratory failure, persistent
unconsciousness, and cardiac arrhythmia) were admitted to
the PICU.
The reasons for poison exposure were classified as
intentional (abuse or suicidal behavior) and accidental. The
variables between intentional and accidental poison expo-
sure were analyzed for significant differences included
patient characteristics, location of poison exposure, clin-
ical presentations, categories of pharmaceutical, period
from exposure to arrival at hospital, and outcomes. In this
study, patients were also divided into four age groups: (1)
an infant group (1 month to 1 year); (2) a preschool age
group (2e6 years); (3) a school-age group (7e12 years); and
(4) an adolescent group (13e18 years). Both the reason for
poison exposure and the gender of patients were also
analyzed across different age groups.
2.4. Data analysis
Descriptive analyses of independent variables (gender, age,
categories of pharmaceutical, clinical presentation, dura-
tion of symptoms, treatments, and outcomes) are reported
as number, percentages, and mean standard deviation.
One-way analysis of variance was used to compare the mean
age of children and the mean total hospital length of stay for
different categories of pharmaceutical. Factors that might
be associated with accidental and intentional poison expo-
sure were analyzed by the Pearson c2 test and t test.
Multiple logistic regression analysis was used to analyze the
predictors for risk of intentional poisoning. In addition, the
reason for poison exposure and the sex of patients were bothanalyzed across different age groups by Pearson c2 test. In
addition, a receiver-operating characteristic (ROC) curve
was drawn and used to pinpoint the cut-off value of age for
high risk of intentional poison exposure. A p value<0.05 was
regarded as significant. All statistical analyses were per-
formed on a personal computer with the statistical package
SPSS for Windows (Version 15.0, SPSS).
3. Results
3.1. Patient characteristics and clinical
presentations
Childhood poisoning accounted for 0.13% (nZ 198) of all
pediatric emergency visits (nZ 148,652) during the study
period. Among them, 87 children with pharmaceutical
poison exposure were analyzed in our study. Their demo-
graphics were presented in Table 1. There were 39 boys
(44.8%) and 48 girls (55.2%). The age group of adolescents
was the greatest representation (48.3%), and mean age was
11.26 6.82 years. The most common location of poison
exposure was at home (89.7%), the major reason for poison
exposure was intentional (60.9%), and all children were
exposed by oral route. The mean period from poison
exposure to arrival at hospital was 3.68 7.29 hours, and
the mean duration of ED observation was 7.83 7.02 hours
(nZ 60).
Among the 87 children, neurologic symptoms were the
most common (56.3%), followed by asymptomatic (16.1%).
The most common duration of major symptoms was 1 day
(70.1%), followed by 2e3 days and 4 days. In the pediatric
ED, the majority of patients received clinical observation
and intravessel fluid supplement only; 11.5% (nZ 10) of the
children were treated with antidotes, and 44.8% (nZ 39) of
children underwent nasogastric tube insertion and irriga-
tion. Among the 10 children who received antidote treat-
ments, 9 of them had lorazepam intoxication and flumazenil
used for treatment. The other one was a case of aspirin
overdose with N-acetylcysteine administrated as antidote.
In all, 21 children (24.1%) were hospitalized because of
severe clinical presentations. Among the 21 children, 4 of
them were admitted to PICU because of unstable vital signs.
The mean duration of hospitalization was 79.71 51.34
hours. All were discharged alive.
3.2. Categories of pharmaceutical and hospital
length of stay
Detailed information on pharmaceutical causing the studied
poisonings is presented in Table 2. Neurologic system agents
(48.3%) were the most common pharmaceutical poisons.
Anxiolytic and hypnotic drugs were the most common drugs
of neurologic system agents (34.5%), followed by antide-
pressant drugs (5.7%), antiepilepsy agents (4.6%), and
narcotics (3.4%). Analgesics were the second most common
pharmaceutical poisons (18.4%). Among them, acetamino-
phen was the most predominant drug (10.3%). Cardiovas-
cular system agents were determined to be the drug of
poisoning in 8% of children, and antihypertensive drugs were
the most common (6.9%) drugs among them. Other agents
Table 1 Patient characteristics and clinical presentations
in children treated for pharmaceutical poison exposure
Poison exposure in
children (nZ 87)
n (%)
Gender
Male 39 (44.8)
Female 48 (55.2)
Age (mean SD, yr old) 11.26 6.82
Infant 9 (10.3)
Preschool age 28 (32.2)
School age 8 (9.2)
Adolescent 42 (48.3)
Location of poison exposure
Home 78 (89.7)
Outside home 9 (10.3)
Reasons for poison exposure
Accidental 34 (39.1)
Intentional 53 (60.9)
Categories of pharmaceutical
Neurologic system agents 42 (48.3)
Analgesics 16 (18.4)
Respiratory system agents 6 (6.9)
Cardiovascular system agents 7 (8)
Metabolic and nutrient agents 6 (6.9)
Others 10 (11.5)
Clinical presentations
Asymptomatic 14 (16.1)
Gastrointestinal symptoms 6 (6.9)
Neurologic symptoms 49 (56.3)
Respiratory symptoms 3 (3.5)
Cardiovascular symptoms 6 (6.9)
Multiple symptoms 5 (5.7)
Others 4 (4.6)
Duration of major symptoms
1 d 61 (70.1)
2e3 d 17 (19.5)
4 d 9 (10.4)
Administration of antidote
Yes 10 (11.5)
No 77 (88.5)
Nasogastric tube insertion
Yes 39 (44.8)
No 48 (55.2)
Hospital admission 21 (24.1)
POU observation 60 (69)
Discharge from the ED 6 (6.9)
SDZ standard deviation; POUZ pediatric observation unit;
EDZ emergency department.
14 Y.-R. Lin et alincluded metabolic and nutrient agents (6.9%), respiratory
system agents (6.9%), and antibiotics (4.6%).
The outcomes of patients are presented in Table 3.
Metabolic and nutrient agents were significantly associatedTable 2 Detailed information on pharmaceuticals which
caused poisoning in children
n (%)
Neurologic system agents (nZ 42)
Anxiolytic and hypnotic drugs 30 (34.5)
Lorazepam 13 (14.9)
Zolpidem 7 (8)
Oxazolam 4 (4.6)
Zopiclone 2 (2.3)
Estazolam 2 (2.3)
Phenobarbital 2 (2.3)
Antidepressant drugs 5 (5.7)
Fluoxetine 3 (3.4)
Imipramine 2 (2.3)
Antiepilepsy 4 (4.6)
Carbamazepine 3 (3.4)
Lamotrigine 1 (1.1)
Narcotics 3 (3.4)
Amphetamine 2 (2.3)
MDMA 1 (1.1)
Cardiovascular system agents (nZ 7)
Antihypertensive drugs 6 (6.9)
Nifedipine 3 (3.4)
Verapamil 1 (1.1)
Captopril 1 (1.1)
Warfain 1 (1.1)
Respiratory system agents (nZ 6)
Bronchodilators 4 (4.6)
b-Adrenergic agonists 2 (2.3)
Theophylline 2 (2.3)
Dextromethorphan 2 (2.3)
Analgesics (nZ 16)
Acetaminophen 9 (10.3)
NSAID 7 (8)
Ibuprofen 3 (3.4)
Diclofenac 2 (2.3)
Ketorolac 1 (1.1)
Aspirin 1 (1.1)
Metabolic and nutrient agents (nZ 6)
Vitamins 4 (4.6)
Iron 1 (1.1)
Atrovastatin 1 (1.1)
Others (nZ 10)
Antibiotics 4 (4.6)
Antacids 3 (3.4)
Antihistamine 2 (2.3)
Diuretics 1 (1.1)
MDMAZ 3,4-methylenedioxymethamphetamine; NSAIDZ non-
steroidal anti-inflammatory drug.
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Pharmaceutical poisoning exposure in children 15with younger age (2.87 1.52 years) (pZ 0.012). Neuro-
logic system agents were associated with the longest
duration of hospital length of stay (45.13 44.46 hours),
and cardiovascular system agents were associated with the
shortest duration of hospital length of stay (5.93 4.31
hours). Four children requiring intensive care were
admitted to the PICU because of critical conditions after
neurologic system agent and intentional analgesic abuse.
Among them, the first one was caused by acetaminophen
overdose which caused acute liver failure, and the other
three cases were amphetamine, lorazepam, and oxazolam
abuse, respectively. After critical care in the PICU, they all
were discharged home, on Days 13, 7, 5, 4, respectively.
3.3. Differences between accidental and
intentional poisoning exposure
In this study, the reasons for poison exposure in children
were classified as accidental and intentional causes. The
differences between the two causes are presented in Table
4. The total hospital length of stay differed significantly
between the two causes of poisoning exposure (pZ 0.008).
Children with intentional poison required longer length of
hospital stay (37.74 46.52 hours) than those with acci-
dental poisoning (20.79 27.52 hours). Male gender was
significantly associated with accidental poisoning, but
female sex was significantly associated with intentional
poisoning (p< 0.001). Multiple logistic regression analysis
revealed that the age of children was the most important
factor associated with intentional poisoning (odds ratio:
1.99, 95% confidence interval: 1.24e3.21, pZ 0.005). Of
the 53 children with intentional poisoning, 2 (3.8%) had past
history of intentional pharmaceutical poison exposure.
Furthermore, female (nZ 34; 81%) sex was more predom-
inant among adolescents (nZ 42) and male (nZ 21; 75%)
gender was more predominant in preschool age group
(nZ 28), respectively (p< 0.001). There was also a signifi-
cant difference in the mean age of children between the
two groups (p< 0.001). The mean age of children treated
for accidental poisoning was greater than that of children
treated for intentional poisoning (4.59 3.32 years vs.
13.84 5.02 years). Moreover, the data revealed that the
proportion of intentional poison exposure increased with
age (infant group, 0/9Z 0%; preschool age group, 8/
28Z 28.6%; school-age group, 5/8Z 62.5%; and adolescent
group, 40/42Z 95.2%) (p< 0.001). We also found that the
ages of patients with intentional poisoning were quite
varied and ranged from 5.1 years to 18 years. The mean age
of patients was analyzed by ROC curve to pinpoint the cut-
off age for high risk of intentional poisoning in the ED. The
area under the ROC curve (AUC) was greater than 0.5, and
the cut-off age for high risk of intentional poison was
10.5 years (AUCZ 0.909 [95% confidence interval
0.843e0.976], sensitivityZ 78%, specificityZ 88.5%, like-
lihood ratioþ: 14.19, likelihood ratio: 0.32, odds ratio:
43.87).
4. Discussion
In central Taiwan, pharmaceutical poisoning exposure in
children is an uncommon reason for visiting the pediatric
Table 4 Significant differences between accidental and intentional poison exposure
Poison exposure in children (nZ 87) p
Accidental (nZ 34) Intentional (nZ 53)
n (%) n (%)
Total hospital length of stay (hr)* 20.79 27.52 37.74 46.52 0.008
Mean age (yr)* 4.59 3.32 13.84 5.02 <0.001
Gender*
Male 25 (73.5) 14 (26.8) <0.001
Female 9 (26.5) 39 (73.2)
Location of poison exposure
Home 30 (88.2) 48 (90.6) 0.560
Outside home 4 (11.8) 5 (9.4)
Clinical presentations
Asymptomatic 8 (23.5) 6 (11.3) 0.218
Gastrointestinal symptoms 2 (5.9) 4 (7.4)
Neurologic symptoms 16 (47.1) 33 (62.3)
Respiratory symptoms 1 (3) 2 (3.8)
Cardiovascular symptoms 4 (11.7) 2 (3.8)
Multiple symptoms 2 (5.8) 3 (5.7)
Other 1 (3) 3 (5.7)
Categories of pharmaceutical*
Neurologic system agents 21 (61.7) 21 (39.7) 0.007
Analgesics 2 (5.8) 14 (26.5)
Respiratory system agents 1 (3) 5 (9.5)
Cardiovascular system agents 4 (11.8) 3 (5.7)
Metabolic and nutrient agents 5 (14.7) 1 (1.9)
Others 1 (3) 9 (16.7)
Hospitalization
Yes 27 (79.4) 37 (69.8) 0.266
No 7 (20.6) 16 (30.2)
Mean period from poison exposure to arrival at hospital 2.37 3.49 4.49 8.80 0.262
* Significant differences between accidental and intentional poison exposure.
16 Y.-R. Lin et alED, accounting for less than 0.1% of all admissions. This
percentage was much lower than 0.15% and 0.14% of total
pediatric emergency admissions, which were reported in
Spain and France, respectively.1,5 The difference could be
because of less frequent poison exposure in central Taiwan,
or the introduction of child-resistant containers for medi-
cines has been effective in terms of primary prevention.
Previous study demonstrated that analgesics, cardio-
vascular medications, theophylline preparations and anti-
depressants, and other psychotropic medications were
more common in adult and elder pharmaceutical poison-
ings.13 In central Taiwan, we found neurologic system
agents were also the most common drug and analgesics
were the second most common drug associated with pedi-
atric pharmaceutical poisoning. Among them, anxiolytic/
hypnotic drugs and acetaminophen were more predominant
in these two categories, respectively. Furthermore, the
mean length of hospital stay was longer in patients with
neurologic system agents and analgesic poisoning than that
in patients with other drugs. Therefore, this finding mayindicate that it is important to determine what kind of
drugs patients have ingested, and detecting the drug levels
(i.e., the level of benzodiazepine, barbiturate, and acet-
aminophen) should be seriously considered for early diag-
nosis if children are unconscious or history is difficult to be
obtain. We found that neurologic system agents were the
most common agents in both the intentional and accidental
pediatric poisonings in Taiwan. Therefore, further
educating the parents to store these agents well to prevent
mistakes by young children is very important. Moreover, the
validity of obtaining neurologic system agents should be
paid more attention with regard to school-age and adoles-
cent children to avoid them being the tool of suicide or
substance abuse.
In this study, the causes for poisoning may also play an
important role related to the outcomes of the patients. We
found that children with intentional poisoning had signifi-
cantly indicated longer length of hospital stay than those
with accidental poisonings, and children who were
admitted to the PICU for critical care were all intentional
Pharmaceutical poisoning exposure in children 17issues. Therefore, understanding the differences between
intentional and accidental poisonings is quite important.
Also, identifying the definite issue may help primary
physicians for performing appropriate assessments.
The first factor associated with the reason for poison was
the age of the poisoned children. The mean age was greater
in children with intentional poisoning than that in children
with accidental poisoning. This finding was similar with
those of some previous studies which addressed a bimodal
age distribution of poisoning in children with toddlers
comprising the majority (mainly accidental poisonings, with
a male preponderance) and a second peak in adolescence
(with an increase in intentional poisonings, and a female
preponderance).1,2,7,8 However, we divided children into
four age groups and found that adolescents were the major
age group (48.3%), and a second peak was the preschool age
group (32.2%). Goto et al14 reported that the percentage of
pediatric poisonings was 37.5% in the infant group in Japan.
However, this number was much smaller in central Taiwan
(only 10.3%) and in American (12.1%). Moreover, the causes
for poison exposure differed significantly between these
two age groups. Intentional poisoning was the most
common reason (93.6%) for poison exposure in adolescents,
whereas accidental poisoning was the majority (71.4%) of
poison exposure in children of preschool age. In our study,
the ROC analysis showed that 10.5 years old was the cut-off
age for high risk of intentional poison in the ED, and the
sensitivity and the specificity were both maximized at this
point. According to our results, of this cut-off age, 78%
sensitivity means that 78% of intentional poisoning could be
found in the ED, and 88.5% specificity means that 88.5% of
accidental poisonings could be sure that they did not suffer
intentional poisoning. Therefore, the cut-off point at 10.5
years old was taken as the best age point for judgment
indicating the highest possibility of intentional poison in the
ED. Therefore, on the basis of this finding, we suggest that
children older than 10.5 years of age with suspected of
suffering from pharmaceutical poison exposure should be
surveyed for the risk of suicide or drug overdose-related
poisoning in the pediatric ED.
In addition, there was also a significant correlation
between the causes of poison exposure and the gender. The
incidence of intentional poisoning was significantly higher
in girls than that in boys, and it was predominant in
adolescence of girls. Therefore, intentional poisoning
needs to be considered regularly in female adolescents with
poison exposure in the pediatric ED, especially when
female patients suffer from altered unconscious status.
There were five most common categories of pharma-
ceutical poisons identified in this study. The categories of
pharmaceutical differed significantly between accidental
and intentional poisonings in children. Antihistamines
and acetaminophen had ever been reported as the most
common agents causing accidental poisoning in children,
respectively,9,15 but in this study, we noted that neurologic
system agents were more common in accidental poisoning
than other agents. Although accidentally poisoning byanalgesics was not common in central Taiwan, there were
still 26.5% of children with intentional poisons treated for
analgesics. So, surveying the risk of analgesics intoxication
in children with intentional poisoning should be noticed by
primary care physicians in the pediatric ED.
5. Conclusions
The detailed categories of pharmaceutical causing pedi-
atric poisoning in central Taiwan were analyzed in our
study. Neurologic system agents and analgesics were
responsible for the majority of cases. Intentional poisoning
caused longer hospital length of stay than accidental
poisoning, and the factors associated with intentional
poisoning were older age, female gender, and the neuro-
logic system agents.
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